Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TATA Health International HoldingsHKSE:01255 +0.24%22 Cyclically Adjusted PS Ratio is 1.53 as of Sep. 06, 2026, which is 629% above its 10-year median of 0.21. GuruFocus rates HKSE:01255 with a GF Score™ of 22/100 and a GF Value™ of HK$0.21 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 884 Manufacturing - Apparel & Accessories companies, TATA Health International Holdings ranks worse than 73.08% on this metric.
The historical rank and industry rank for TATA Health International Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:
HKSE:01255'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.14 Med: 0.21 Max: 2.58
Current: 1.53
During the past 13 years, TATA Health International Holdings's highest Cyclically Adjusted PS Ratio was 2.58. The lowest was 0.14. And the median was 0.21.
HKSE:01255's Cyclically Adjusted PS Ratio is ranked worse than 73.08% of 884
companies
in the Manufacturing - Apparel & Accessories industry
Industry Median: 0.66
vs HKSE:01255: 1.53
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
TATA Health International Holdings's adjusted revenue per share data of for the fiscal year that ended in Dec25 was HK$0.411. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is HK$1.37 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
TATA Health International Holdings (HKSE:01255) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
TATA Health International Holdings Cyclically Adjusted PS Ratio Related Terms
TATA Health International Holdings Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TATA Health International Holdings Cyclically Adjusted PS Ratio Chart
HKSE:01255 vs NKE, DECK, ONON: Cyclically Adjusted PS Ratio Comparison
For the Footwear & Accessories subindustry, TATA Health International Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TATA Health International Holdings Cyclically Adjusted PS Ratio vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, TATA Health International Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where TATA Health International Holdings's Cyclically Adjusted PS Ratio falls into.
TATA Health International Holdings Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 1.53 mean?
TATA Health International Holdings (HKSE:01255) has a Cyclically Adjusted PS Ratio of 1.53 as of Sep. 06, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on TATA Health International Holdings and its competitors. This is 629% above median its historical median of 0.21. Over the past decade, TATA Health International Holdings' Cyclically Adjusted PS Ratio has ranged from 0.14 to 2.58. According to the industry distribution chart, TATA Health International Holdings ranks #646 out of 884 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 73.1%.
Is TATA Health International Holdings' Cyclically Adjusted PS Ratio too high?
TATA Health International Holdings' current Cyclically Adjusted PS Ratio of 1.53 is 629% above median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 2.58. The Manufacturing - Apparel & Accessories industry median Cyclically Adjusted PS Ratio is 0.66. TATA Health International Holdings' value of 1.53 is 131.8% above this industry median. Based on the distribution chart, TATA Health International Holdings ranks #646 out of 884 companies in the Manufacturing - Apparel & Accessories industry, which is below the industry midpoint. Overall, TATA Health International Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TATA Health International Holdings' Cyclically Adjusted PS Ratio compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, TATA Health International Holdings ranks #646 out of 884 companies for Cyclically Adjusted PS Ratio. This places TATA Health International Holdings in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 0.66. TATA Health International Holdings' value of 1.53 is 131.8% above this benchmark. Historically, TATA Health International Holdings' own Cyclically Adjusted PS Ratio has ranged from 0.14 to 2.58 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 0.66, TATA Health International Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Manufacturing - Apparel & Accessories company?
The median Cyclically Adjusted PS Ratio among Manufacturing - Apparel & Accessories companies is 0.66, based on 884 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TATA Health International Holdings's current Cyclically Adjusted PS Ratio of 1.53 is 131.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on TATA Health International Holdings and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Cyclically Adjusted PS Ratio is 0.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TATA Health International Holdings's current Cyclically Adjusted PS Ratio is 1.53, which is 629% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TATA Health International Holdings stock overvalued right now?
Based on GuruFocus' analysis, TATA Health International Holdings (HKSE:01255) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.21, compared to a current price of HK$2.10 — trading 900% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 1.53, which is 629% above median its 10-year median of 0.21 and 131.8% above the Manufacturing - Apparel & Accessories industry median of 0.66. TATA Health International Holdings' overall GF Score™ is 22/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For TATA Health International Holdings (HKSE:01255), the current Cyclically Adjusted PS Ratio is 1.53 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TATA Health International Holdings (HKSE:01255) Overvalued in 2026?
Based on GuruFocus' analysis, TATA Health International Holdings stock appears to be overvalued.
The current stock price of HK$2.10 is trading 900% above its estimated GF Value™ of HK$0.21.
GuruFocus considers TATA Health International Holdings to be Significantly Overvalued.
Key valuation signals for HKSE:01255:
Cyclically Adjusted PS Ratio: 1.53 (629% above median its 10-year median of 0.21)
GF Value™: HK$0.21 vs. price of HK$2.10 (900% above fair value)
Industry Position: 131.8% above the Manufacturing - Apparel & Accessories median (#646 of 884)
No single metric tells the full story. See the HKSE:01255 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TATA Health International Holdings Ltd is an investment holding company. Through its subsidiaries, the company operates in four segments: Trading of footwear products, Trading of healthcare products, Financial services, and Online medical services. The majority of its revenue comes from the Trading of footwear products. Geographically, the Group generates maximum revenue from Hong Kong, and the rest from Macau.
22GF Score
Get the complete analysis for HKSE:01255
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01255 has been successfully added to your 
